Literature DB >> 31076391

Refractory sarcoidosis-like systemic granulomatosis responding to ruxolitinib.

Michael Levraut1, Nihal Martis2, Philippe Viau3, Felipe Suarez4, Viviane Queyrel2.   

Abstract

Entities:  

Keywords:  patient perspective; sarcoidosis; treatment

Mesh：

Substances：

Year:  2019        PMID： 31076391     DOI： 10.1136/annrheumdis-2019-215387

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

Review 1.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

2.  Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis.

Authors:  William Damsky; Alice Wang; Daniel J Kim; Bryan D Young; Katelyn Singh; Michael J Murphy; Joseph Daccache; Abigale Clark; Ruveyda Ayasun; Changwan Ryu; Meaghan K McGeary; Ian D Odell; Ramesh Fazzone-Chettiar; Darko Pucar; Robert Homer; Mridu Gulati; Edward J Miller; Marcus Bosenberg; Richard A Flavell; Brett King
Journal:  Nat Commun       Date:  2022-06-06       Impact factor: 17.694

3.  Compassionate use of ruxolitinib in patients with SARS-Cov-2 infection not on mechanical ventilation: Short-term effects on inflammation and ventilation.

Authors:  Andrea Mortara; Simone Mazzetti; Davide Margonato; Pietro Delfino; Chiara Bersano; Francesco Catagnano; Marinella Lauriola; Paolo Grosso; Gianluca Perseghin; Giovanbattista Ippoliti
Journal:  Clin Transl Sci       Date:  2021-01-27       Impact factor: 4.689

4.  Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review.

Authors:  Carmen Álvarez-Reguera; Diana Prieto-Peña; Alba Herrero-Morant; Lara Sánchez-Bilbao; José Luis Martín-Varillas; Elena González-López; María Gutiérrez-Larrañaga; David San Segundo; Rosalía Demetrio-Pablo; Gonzalo Ocejo-Vinyals; Miguel A González-Gay; Ricardo Blanco
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-04-29       Impact factor: 3.625

Review 5.  Refractory Sarcoidosis: A Review.

Authors:  Thomas El Jammal; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Dominique Valeyre; Pascal Sève
Journal:  Ther Clin Risk Manag       Date:  2020-04-17       Impact factor: 2.423

6.  Treatment of Multiorgan Sarcoidosis With Tofacitinib.

Authors:  William Damsky; Bryan D Young; Brett Sloan; Edward J Miller; J Antonio Obando; Brett King
Journal:  ACR Open Rheumatol       Date:  2020-01-09

Review 7.  Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis.

Authors:  Gonçalo Boleto; Matheus Vieira; Anne Claire Desbois; David Saadoun; Patrice Cacoub
Journal:  Front Med (Lausanne)       Date:  2020-11-24

Review 8.  Sarcoidosis: Progression to the chronic stage and pathogenic based treatment (narrative review).

Authors:  Anna Malkova; Yulia Zinchenko; Anna Starshinova; Dmitriy Kudlay; Igor Kudryavtsev; Anzhela Glushkova; Piotr Yablonskiy; Yehuda Shoenfeld
Journal:  Front Med (Lausanne)       Date:  2022-09-06

Review 9.  The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature.

Authors:  Alice Wang; Katelyn Singh; Wael Ibrahim; Brett King; William Damsky
Journal:  Yale J Biol Med       Date:  2020-03-27

10.  Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis.

Authors:  Ronan Talty; William Damsky; Brett King
Journal:  JAAD Case Rep       Date:  2021-08-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.